Promote Healthy People, Healthy Planet and Improve Care for All
New study supports remdesivir as COVID-19 treatment
July 9, 2020 Researchers at the University of North Carolina at Chapel Hill, Vanderbilt University Medical Center and Gilead Sciences report that remdesivir greatly inhibited SARS-CoV-2, the virus that causes COVID-19, in human lung cell cultures and also improved lung function in mice infected with the virus.
LaVange on front lines of effort to develop drugs for COVID-19
July 6, 2020 The National Institutes of Health have launched a public-private partnership to identify effective treatments for COVID-19. Dr. Lisa LaVange of the Gillings School is supporting two committees in the partnership.
Seven new Gillings Innovation Labs will tackle COVID-19
July 6, 2020 Exactly how does coronavirus spread in the air? What will get kids’ vaccinations back on track across the United States? How can public health practitioners work with church communities to spread accurate information about COVID-19? These are just three of the questions being explored by Gillings School researchers and their collaborators through a special COVID-19 round of Gillings Innovation Laboratory awards.
Groundbreaking study reveals genetic markers for Type 2 diabetes in East Asians
July 6, 2020 A recent study — the largest of its kind in any non-European population — demonstrates that while different populations of people share similar genetic predispositions for Type 2 diabetes, they also have some genetic variations that can alter their susceptibility to developing the disease.
Koonin, an original 'architect of social distancing,' develops guidance for COVID-19 response
June 29, 2020 In January, the U.S. Centers for Disease Control and Prevention asked Gillings School alumna and adjunct faculty member Dr. Lisa Koonin, one of the "architects of social distancing," to develop guidance for the health system's response to COVID-19.
Gillings researchers identify potential strategy for rapid scale-up of COVID-19 testing
June 29, 2020 Researchers at the Gillings School have identified a possible testing model for SARS-CoV-2 that could rapidly and efficiently screen 2 to 20 times as many people as an individual molecular-based test could.
Most medical home care practices provide comparable quality mental health care, regardless of setting
June 22, 2020 Medical home care has been proposed as a solution to help those with serious mental illness use primary care more often, and new research from UNC has revealed that most medical homes provide a similar quality of care to these patients regardless of practice type.
The Gillings Community Responds to COVID-19: Protection for Rural Farmworkers
June 22, 2020 As part of her work coordinating COVID-19 protections for Spanish-speaking farmworkers in rural N.C., online MPH@UNC student Courtney Peragallo has seen the importance of applying public health principles in ways that promote empathy and cultural sensitivity.
Giving a global voice to minority smoking inequities
June 22, 2020 A UNC-Chapel Hill student-led public health team places third among 3,500 participants in Oxford University’s global systems mapping competition, exploring racial and ethnic disparities in tobacco control.
UNC-Chapel Hill researchers create new type of COVID-19 antibody test
June 15, 2020 Scientists have created a test that pinpoints human antibodies specific to a unique part of the SARS-CoV-2 spike protein. The test can help document COVID-19 infections, identify asymptomatic virus infection and measure the level of immunity in individuals.
